G-CSF in patients suffering from late revascularised ST elevation myocardial infarction: final 1-year-results of the G-CSF-STEMI Trial.

[1]  J. Kastrup,et al.  Instent neointimal hyperplasia after percutaneous intervention for ST-elevation myocardial infarction and treatment with granulocyte-colony stimulating factor. Results from the stem cells in myocardial infarction (STEMMI) trial. , 2010, International journal of cardiology.

[2]  G. Assmann,et al.  Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow‐derived progenitor cells via the CXCR‐4/SDF‐1 axis , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  A. Coats,et al.  Ethical authorship and publishing. , 2009, International journal of cardiology.

[4]  S. Rankin,et al.  Differential mobilization of subsets of progenitor cells from the bone marrow. , 2009, Cell stem cell.

[5]  R. David,et al.  Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow. , 2008, Experimental hematology.

[6]  R. Bolli,et al.  Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. , 2008, American heart journal.

[7]  S. Schoenberg,et al.  G-CSF in patients suffering from late revascularized ST elevation myocardial infarction: analysis on the timing of G-CSF administration. , 2008, Experimental hematology.

[8]  R. David,et al.  G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells. , 2008, Experimental hematology.

[9]  J. Kastrup,et al.  Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. , 2008, Journal of the American College of Cardiology.

[10]  S. Grundmann,et al.  Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. , 2008, Cardiovascular research.

[11]  W. Franz,et al.  Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells. , 2007, American journal of physiology. Endocrinology and metabolism.

[12]  I. Komuro,et al.  Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction. , 2007, International journal of cardiology.

[13]  Richard T. Lee,et al.  Local Delivery of Protease-Resistant Stromal Cell Derived Factor-1 for Stem Cell Recruitment After Myocardial Infarction , 2007, Circulation.

[14]  J. Kastrup,et al.  Bone Marrow–Derived Mesenchymal Cell Mobilization by Granulocyte-Colony Stimulating Factor After Acute Myocardial Infarction: Results From the Stem Cells in Myocardial Infarction (STEMMI) Trial , 2007, Circulation.

[15]  S. Schoenberg,et al.  Autologous Bone Marrow Stem Cell Mobilization Induced by Granulocyte Colony-Stimulating Factor After Subacute ST-Segment Elevation Myocardial Infarction Undergoing Late Revascularization : Final Results From the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infar , 2006 .

[16]  C. Heeschen,et al.  Effects of Granulocyte Colony Simulating Factor on Functional Activities of Endothelial Progenitor Cells in Patients With Chronic Ischemic Heart Disease , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[17]  W. Franz,et al.  Stem cell therapy after myocardial infarction: ready for clinical application? , 2006, Current opinion in molecular therapeutics.

[18]  E. Taraldsrud,et al.  Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[19]  A. Zeiher,et al.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[20]  S. Verma,et al.  Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. , 2006, The Journal of clinical investigation.

[21]  I. Hoefer,et al.  G‐CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  H. Johnsen,et al.  Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial Infarction (STEMMI) Trial , 2006, Circulation.

[23]  M. Schwaiger,et al.  Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. , 2006, JAMA.

[24]  G. Breithardt,et al.  G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis , 2006, The Journal of experimental medicine.

[25]  S. Schoenberg,et al.  Phase-sensitive inversion-recovery MR imaging in the detection of myocardial infarction. , 2005, Radiology.

[26]  C. Nienaber,et al.  Preservation From Left Ventricular Remodeling by Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Use of Granulocyte-Colony–Stimulating Factor (FIRSTLINE-AMI) , 2005, Circulation.

[27]  R. Ferrari,et al.  Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. , 2005, European heart journal.

[28]  C. Nienaber,et al.  Prevention of Left Ventricular Remodeling With Granulocyte Colony-Stimulating Factor After Acute Myocardial Infarction: Final 1-year Results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE- , 2005, Circulation.

[29]  I. Komuro,et al.  G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes , 2005, Nature Medicine.

[30]  I. Komuro,et al.  Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. , 2004, Biochemical and biophysical research communications.

[31]  Yan Huang,et al.  Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury , 2004, Circulation.

[32]  P. Merlet,et al.  Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. , 2003, Blood.

[33]  Eric J Topol,et al.  Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy , 2003, The Lancet.

[34]  R. David,et al.  Stem-cell homing and tissue regeneration in ischaemic cardiomyopathy , 2003, The Lancet.

[35]  T. Murohara,et al.  Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction , 2001, Circulation.

[36]  D. Bodine,et al.  Transplanted Adult Bone Marrow Cells Repair Myocardial Infarcts in Mice , 2001, Annals of the New York Academy of Sciences.

[37]  S. Schoenberg,et al.  Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarc , 2006, Journal of the American College of Cardiology.